A Study of SH-1028 Tablets Versus Gefitinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer
Clinical trial NCT04239833 · UNKNOWN
Trial details
- NCT number
- NCT04239833
- Sponsor
- Nanjing Sanhome Pharmaceutical, Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-31
- Primary completion
- 2022-01-31
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.